Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 17/20 | 0.49 |
| ▸ | MAP2K2 | P36507 | 5/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | PTGFR | P43088 | 1/20 | 0.39 |
| ▸ | FLT1 | P17948 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31376766 | 0.81 | MAP2K1 (0.56) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL31135614 | 0.80 | MAP2K1 (0.59) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL23851383 | 0.80 | MAP2K1 (0.59) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL31135631 | 0.75 | MAP2K1 (0.50) | MAP2K1MAP2K2IDO1FLT1 | |
| SCHEMBL23850846 | 0.75 | MAP2K1 (0.50) | MAP2K1MAP2K2IDO1FLT1 | |
| SCHEMBL24196106 | 0.73 | MAP2K1 (0.48) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL24558816 | 0.73 | MAP2K1 (0.51) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL23852559 | 0.73 | MAP2K1 (0.52) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL31403386 | 0.73 | MAP2K1 (0.52) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL23851097 | 0.73 | MAP2K1 (0.62) | MAP2K1MAP2K2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113473978-B | Cyanoarene-aniline compounds for the treatment of skin disorders | 恩福莱克逊治疗有限公司 | 2025-03-28 | — | — | CN | disclosed |